This website provides information on patients with mutations in the CHMP3 gene, including clinical data, molecular data, management and research options.

Hereditary Spastic Paraplegia caused by mutations in the CHMP3 gene is a neurodegenerative disorder, characterized by early onset spastic paraplegia, associated with progressive developmental delay.

This website was created to share and collect information about clinic, management and research projects to gather more knowledge and provide better treatment of patients with mutations in the CHMP3 gene.

Nada Danial-Farran, PhD, Genetic institute, Emek medical center, Afula, Israel, nada_fa@clalit.org.il
Dr. Eran Cohen-Barak, MD, Department of dermatology, Emek medical center; The Ruth and Bruce Rappaport faculty of medicine, Technion, Afula, Israel, eran_co@clalit.org.il
Prof. Stavit A. Shalev, MD, Genetic institute, Emek medical center; The Ruth and Bruce Rappaport faculty of medicine, Technion, Afula, Israel, stavit_Sh@clalit.org.il